Abstract
Aims and Objectives: The biological dataset was retrieved from two series of α-glucosidase inhibitors synthesized by Rahim et al. and Taha et al. and consisted of a total of 46 (forty-six) α- glucosidase inhibitors.
Methods: The α-glucosidase inhibitory IC50 values (μM; performed against α-glucosidase from Saccharomyces cerevisiae) were converted into negative logarithmic units (pIC50). The CoMFA and CoMSIA models were developed using 37 as a training set, and externally validated using 9 as a test set. The CoMFA models MMFF94 were generated, ranging from 3.4661 to 5.2749 using leave-oneout PLS analysis cross-validated correlation coefficient q2 0.787, a high non-cross-validated correlation coefficient r2 0.819, with a low Standard Error Estimation (SEE) 0.041, F value 1316.074 and r2pred 0.996.
Results: The steric and electrostatic fields contributions were 0.507 and 0.493, respectively. The CoMSIA model q2 0.805, r2 0.833 was attained, (SEE) 0.065, F value 520.302 and r2pred 0.990. Contribution of steric, electrostatic, hydrophobic, donor and acceptor fields was 0.151, 0.268, 0.223, 0.234, 0.124, respectively.
Conclusion: The HQSAR model of the training set exhibits a significant cross-validated correlation coefficient q2 0.800 and non-cross-validated correlation coefficient r2 0.943.
Keywords: CoMFA, CoMSIA, HQSAR, pharmacophore mapping, docking, α-glucosidase inhibitor.
Graphical Abstract
Current Drug Discovery Technologies
Title:Molecular Modelling Studies on Thiazole-Based α-Glucosidase Inhibitors Using Docking and CoMFA, CoMSIA and HQSAR
Volume: 18 Issue: 6
Author(s): Deshbandhu Joshi*, Shourya Yadav, Rajesh Sharma, Mitrunjaya Pandya and Raghvendra Singh Bhadauria
Affiliation:
- School of Pharmacy, Devi Ahilya Vishwavidyalya Takshashila Campus, Khandwa Road, Indore-452001 Madhya Pradesh,India
Keywords: CoMFA, CoMSIA, HQSAR, pharmacophore mapping, docking, α-glucosidase inhibitor.
Abstract:
Aims and Objectives: The biological dataset was retrieved from two series of α-glucosidase inhibitors synthesized by Rahim et al. and Taha et al. and consisted of a total of 46 (forty-six) α- glucosidase inhibitors.
Methods: The α-glucosidase inhibitory IC50 values (μM; performed against α-glucosidase from Saccharomyces cerevisiae) were converted into negative logarithmic units (pIC50). The CoMFA and CoMSIA models were developed using 37 as a training set, and externally validated using 9 as a test set. The CoMFA models MMFF94 were generated, ranging from 3.4661 to 5.2749 using leave-oneout PLS analysis cross-validated correlation coefficient q2 0.787, a high non-cross-validated correlation coefficient r2 0.819, with a low Standard Error Estimation (SEE) 0.041, F value 1316.074 and r2pred 0.996.
Results: The steric and electrostatic fields contributions were 0.507 and 0.493, respectively. The CoMSIA model q2 0.805, r2 0.833 was attained, (SEE) 0.065, F value 520.302 and r2pred 0.990. Contribution of steric, electrostatic, hydrophobic, donor and acceptor fields was 0.151, 0.268, 0.223, 0.234, 0.124, respectively.
Conclusion: The HQSAR model of the training set exhibits a significant cross-validated correlation coefficient q2 0.800 and non-cross-validated correlation coefficient r2 0.943.
Export Options
About this article
Cite this article as:
Joshi Deshbandhu *, Yadav Shourya, Sharma Rajesh , Pandya Mitrunjaya and Bhadauria Singh Raghvendra , Molecular Modelling Studies on Thiazole-Based α-Glucosidase Inhibitors Using Docking and CoMFA, CoMSIA and HQSAR, Current Drug Discovery Technologies 2021; 18 (6) : e130921187100 . https://dx.doi.org/10.2174/1570163817666201022111213
DOI https://dx.doi.org/10.2174/1570163817666201022111213 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Ginsenoside Rb1 Directly Scavenges Hydroxyl Radical and Hypochlorous Acid
Current Pharmaceutical Design The Role of Regulatory T Cells in Contact Hypersensitivity
Recent Patents on Inflammation & Allergy Drug Discovery Triiodothyronine (T3) Effects on Cardiovascular System in Patients with Heart Failure
Recent Patents on Cardiovascular Drug Discovery Essentials of Daflon 500 mg: From Early Valve Protection to Long-Term Benefits in the Management of Chronic Venous Disease
Current Pharmaceutical Design Adeno-associated Viral Vectors for Correction of Inborn Errors of Metabolism: Progressing Towards Clinical Application
Current Pharmaceutical Design Computational Study of Nanosized Drug Delivery from Cyclodextrins, Crown Ethers and Hyaluronan in Pharmaceutical Formulations
Current Topics in Medicinal Chemistry Targeting Water in the Brain: Role of Aquaporin-4 in Ischemic Brain Edema
Current Drug Targets Implications for Endothelium-Derived Hyperpolarizing Factor (EDHF) in Womens Cardiovascular Health
Current Women`s Health Reviews P-Chiral Oligonucleotides in Biological Recognition Processes
Current Topics in Medicinal Chemistry Metabolic Targets of Cardiac HormonesTherapeutic Anti-Cancer Effects
Current Pharmaceutical Design Silencing the Brain May be Better than Stimulating it. The GABA Effect
Current Pharmaceutical Design Modulation Effects of Piracetam and Ginkgo biloba on the Cognitive and Working Memory Functions: Psychometric Study
Current Psychopharmacology Role of Isoprenoid Compounds on Angiogenic Regulation: Opportunities and Challenges
Current Medicinal Chemistry Mesenchymal Stem Cells in Cartilage Regeneration
Current Stem Cell Research & Therapy Discovery and Hit to Lead Optimization of Novel Combretastatin A-4 Analogues: Dependence of C-Linker Length and Hybridization
Anti-Cancer Agents in Medicinal Chemistry Eco-friendly Synthesis of Pyrido[2,3-d]pyrimidine Analogs and Their Anticancer and Tyrosine Kinase Inhibition Activities
Anti-Cancer Agents in Medicinal Chemistry Healing the Diabetic Heart: Modulation of Cardiometabolic Syndrome through Peroxisome Proliferator Activated Receptors (PPARs)
Current Molecular Pharmacology The Effect of First-in-Class Small Molecule RhoA Inhibitor, HL07, on the Phenylephrine-induced Artery Contraction
Current Pharmaceutical Design New Insights for Multifactorial Disease Therapy: The Challenge of the Symbiotic Drugs
Current Drug Therapy Molecular Pathways of Endothelial Cell Activation for (Targeted) Pharmacological Intervention of Chronic Inflammatory Diseases
Current Vascular Pharmacology